Implications of low muscle mass across the continuum of care: a narrative review

CM Prado, SA Purcell, C Alish, SL Pereira… - Annals of …, 2018 - Taylor & Francis
Abnormalities in body composition can occur at any body weight. Low muscle mass is a
predictor of poor morbidity and mortality and occurs in several populations. This narrative …

Computed tomography‐defined low skeletal muscle index and density in cancer patients: observations from a systematic review

J McGovern, RD Dolan, PG Horgan… - Journal of cachexia …, 2021 - Wiley Online Library
Background Computed tomography (CT) analysis of body composition has garnered interest
as a potential prognostic tool in those with cancer. A range of pre‐defined thresholds …

The prognostic value of sarcopenia in oesophageal cancer: a systematic review and meta‐analysis

P Fang, J Zhou, X Xiao, Y Yang, S Luan… - Journal of cachexia …, 2023 - Wiley Online Library
The loss of skeletal muscle mass and function is defined as sarcopenia, which might
develop in elderly patients with cancers. It has been indicated as a potential negative factor …

Effects of weight loss and sarcopenia on response to chemotherapy, quality of life, and survival

AM Ryan, CM Prado, ES Sullivan, DG Power, LE Daly - Nutrition, 2019 - Elsevier
It has frequently been shown that patients with cancer are one of the largest hospital patient
groups with a prevalence for malnutrition. Weight loss is a frequent manifestation of …

Prognostication in advanced cancer: update and directions for future research

D Hui, CE Paiva, EG Del Fabbro, C Steer… - Supportive Care in …, 2019 - Springer
The objective of this review is to provide an update on prognostication in patients with
advanced cancer and to discuss future directions for research in this field. Accurate …

CT-assessed sarcopenia is a predictive factor for both long-term and short-term outcomes in gastrointestinal oncology patients: a systematic review and meta-analysis

H Su, J Ruan, T Chen, E Lin, L Shi - Cancer Imaging, 2019 - Springer
Background The impact of sarcopenia on the outcome of gastrointestinal (GI) oncological
patients is still controversial. We aim to discuss the prevalence of sarcopenia and its relation …

Multimodal prehabilitation during neoadjuvant therapy prior to esophagogastric cancer resection: effect on cardiopulmonary exercise test performance, muscle mass …

SK Allen, V Brown, D White, D King, J Hunt… - Annals of surgical …, 2022 - Springer
Background Neoadjuvant therapy reduces fitness, muscle mass, and quality of life (QOL).
For patients undergoing chemotherapy and surgery for esophagogastric cancer …

Assessment of body composition and sarcopenia in patients with esophageal cancer: a systematic review and meta-analysis

PR Boshier, R Heneghan, SR Markar… - Diseases of the …, 2018 - academic.oup.com
There has recently been increased interest in the assessment of body composition in
patients with esophageal cancer for the purpose of nutritional evaluation and …

Chemotherapy-induced sarcopenia

F Bozzetti - Current treatment options in oncology, 2020 - Springer
Opinion statement Sarcopenia is being consistently recognized as a condition not only
associated with the presence of a malignancy but also induced by the oncologic therapies …

Preoperative sarcopenia is a predictor of poor prognosis of esophageal cancer after esophagectomy: a comprehensive systematic review and meta-analysis

HY Deng, P Zha, L Peng, L Hou… - Diseases of the …, 2019 - academic.oup.com
The impact of preoperative sarcopenia on long-term survival of esophageal cancer patients
after esophagectomy remains unclear. We conducted an updated meta-analysis focusing on …